Aug 14, 2020
Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results
Jun 01, 2020
Camurus Announces Submission of Request for Final Approval of Brixadi(TM) for the Treatment of Opioid Use Disorder in the US
Jun 01, 2020
Braeburn Submits Request for Final Approval of BRIXADI(TM) (buprenorphine) Extended-Release Injection for the Treatment of Opioid Use Disorder
May 18, 2020
SaVida Health, an Outpatient Medical Practice for Opioid and Alcohol Addiction, now accepting patients from Downeast Maine.
May 15, 2020
Titan Pharmaceuticals Reports First Quarter 2020 Financial Results
May 11, 2020
Alkermes Announces Expansion of Patient Services and Provider Network to Support Uninterrupted Access to ARISTADA® and VIVITROL® During COVID-19 Crisis
May 11, 2020
Titan Pharmaceuticals To Report First Quarter 2020 Financial Results On May 15, 2020
Apr 27, 2020
National Medical Director Dr. Peter Coleman Voted Top Addiction Doc
Apr 16, 2020
SUBLOCADE® Long-Term Safety Data Published in Journal of Clinical Psychopharmacology
Apr 02, 2020
BAART Programs Opens Outpatient, Opioid Addiction Treatment Programs in Bremerton & Port Angeles, Washington
Mar 26, 2020
Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020
Mar 23, 2020
One-Year Outcomes of Real-World RECOVER(TM) Study Published in Journal of Addiction Medicine
Mar 20, 2020
Tara Healthcare Increases Access to Suboxone Doctors via Telemedicine During COVID-19
Mar 12, 2020
Foundation for Opioid Response Efforts (FORE) Announces $10.1 Million in Grants to Improve Access to Opioid Treatment
Mar 05, 2020
Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants
Feb 25, 2020
Medication Treatments Led to 80 Percent Lower Risk of Fatal Overdose for Patients with Opioid Use Disorder than Medication-free Treatments
Jan 29, 2020
Promising Results From Human PK Study Assessing Novel Ketorolac Formulations for Treatment of Pain
Jan 13, 2020
Baymark Health Services Opens Second Opioid Treatment Program In Columbus Ohio
Jan 13, 2020
Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule
Jan 08, 2020
BayMark Health Services Opioid Treatment Programs Nationwide Now Accept Medicare